To include your compound in the COVID-19 Resource Center, submit it here.

Plazomicin: Phase III started

Achaogen enrolled the first patient in an open-label, international Phase III trial comparing IV plazomicin plus meropenem or tigecycline vs.

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE